New hope for advanced cancers: experimental drug EIK1005 enters human trials
NCT ID NCT07262619
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called EIK1005, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the drug shrinks tumors. About 160 adults with certain cancer types (including MSI-H or dMMR tumors) will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Calvary Mater Newcastle Hospital
RECRUITINGWaratah, New South Wales, Australia
-
Chris O'Brien Lifehouse (Sydney Cancer Centre)
RECRUITINGCamperdown, Victoria, Australia
-
GenesisCare North Shore (Oncology)
NOT_YET_RECRUITINGSaint Leonards, New South Wales, Australia
-
Grampians Health
RECRUITINGBallarat, Victoria, Australia
-
Health New Zealand
RECRUITINGWellington, New Zealand
-
Memorial Sloan Kettering Cancer Center (MSKCC)
NOT_YET_RECRUITINGNew York, New York, 10022, United States
-
Morristown Medical Center
NOT_YET_RECRUITINGMorristown, New Jersey, 07960, United States
-
Oncology Clinics Victoria (OCV) - Cabrini Brighton Hospital
NOT_YET_RECRUITINGFrankston, Victoria, 3199, Australia
-
Peninsula and Southeast Oncology (PASO) Medical
RECRUITINGFrankston, Victoria, Australia
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A safer first cut? trial tests two laparoscopic entry points for endometrial cancer surgery
- Could an AI-Designed pill take on Hard-to-Treat cancers?
- Can a new nucleotide analogue boost cancer treatment?
- Can a new Liposome-Wrapped drug shrink Hard-to-Treat solid tumors?
- Can a new antibody help the immune system fight advanced cancers?
- Can an experimental pill slow advanced solid tumors? a phase 1 trial puts HW221043 to the test.